Advertisement

Topics

Grifols adds ID RHD XT diagnostic kit to its molecular portfolio

05:01 EDT 23 Jun 2017 | FinanzNachrichten

- Grifols receives CE mark approval for ID RHD XT - The diagnostic kit detects the most relevant RHD variants allowing more rational usage of D negative units BARCELONA, Spain, June 23, 2017 /PRNe...

Original Article: Grifols adds ID RHD XT diagnostic kit to its molecular portfolio

NEXT ARTICLE

More From BioPortfolio on "Grifols adds ID RHD XT diagnostic kit to its molecular portfolio"

Advertisement
Quick Search
Advertisement
Advertisement